The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjects.

Author: BrandtJohn T, FaridNagy A, JakubowskiJoseph A, LiGrace Ying, NaganumaHideo, PayneChristopher D, SmallDavid S, WeerakkodyGovinda J, WintersKenneth J

Paper Details 
Original Abstract of the Article :
Prasugrel (CS-747, LY640315), a novel thienopyridine, is a potent and orally active antiplatelet agent in vivo. The aims of this double-blind, double-dummy, placebo-controlled, randomized, parallel group phase 1 study were to investigate the antiplatelet effects of prasugrel after oral administratio...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/16633079

データ提供:米国国立医学図書館(NLM)

Prasugrel: A New Antiplatelet Agent in the Desert of Cardiovascular Disease

Cardiovascular disease is a major public health concern, and the search for effective treatments is an ongoing journey through a complex and often challenging desert. This study explores the potential of prasugrel, a novel antiplatelet drug, in preventing blood clots and reducing the risk of heart attacks and strokes. The study found that prasugrel effectively inhibited platelet aggregation, a key factor in blood clot formation. This research is like discovering a powerful weapon in the desert of cardiovascular disease, offering a potential solution for preventing serious complications.

Prasugrel: A Powerful Antiplatelet Agent

The study's findings suggest that prasugrel is a potent and effective antiplatelet agent. The researchers observed rapid and sustained inhibition of platelet aggregation, suggesting that prasugrel could be a valuable tool for preventing blood clots and reducing the risk of cardiovascular events. This research is like a map leading us towards a more effective and proactive approach to managing cardiovascular disease, offering hope for a brighter future for those at risk.

Navigating the Desert of Cardiovascular Disease with Prasugrel

This study highlights the potential of prasugrel as a valuable addition to the armamentarium of antiplatelet agents. The researchers' findings suggest that prasugrel could be an effective and well-tolerated treatment option, offering hope for those seeking to prevent cardiovascular complications. This research is like a camel caravan traversing the desert of cardiovascular disease, leading us toward a better understanding of this condition and the development of more effective treatments.

Dr.Camel's Conclusion

This study demonstrates the effectiveness of prasugrel as a potent antiplatelet agent, offering hope for preventing cardiovascular complications. This research, like a journey through the desert of cardiovascular disease, leads us towards a better understanding of this condition and the development of more effective treatments.

Date :
  1. Date Completed 2006-07-10
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16633079

DOI: Digital Object Identifier

00005344-200603000-00007

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.